Pharmacist intervention enhances adherence to orlistat therapy

Area of Science:

• Pharmacology
• Obesity Management
• Patient Adherence

Background:

• The nationwide obesity epidemic necessitates increased pharmacist intervention, particularly in community settings.
• Community pharmacists' regular public interaction offers a unique opportunity for obesity management support.
• Hypothesis: Enhanced pharmacist support can improve therapeutic outcomes for patients using weight-loss medication.

Purpose of the Study:

• To evaluate the impact of community pharmacist support on patient persistence with orlistat therapy.
• Assessing the role of pharmaceutical care in improving adherence to weight-loss medication.

Main Methods:

• Pharmacists received training in basic obesity management.
• Patients prescribed orlistat in an outpatient nutrition program were recruited.
• Intervention group received pharmaceutical care; control group received usual care.

Main Results:

• The intervention group showed significantly greater persistence with orlistat therapy (p = 0.006).
• More patients in the intervention group completed the 26-week study (7 vs. 2; p = 0.046).
• No significant difference in percent weight loss was observed between groups (p > 0.05).

Conclusions:

• Community pharmacist support led to improved patient persistence with orlistat.
• Pharmaceutical care positively influenced the outcome of orlistat therapy in this pilot study.
• Pharmacist-led interventions show promise in enhancing medication adherence for obesity treatment.